Clin2
NCT06826872Likely a fitRecruiting

Testing SPC1001 for essential hypertension

Hypertension, EssentialCardiovascular DiseasesCardiology

Part of Heart & circulation clinical trials.

This trial tests an oral medication called SPC1001 to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure not caused by another condition). It may help if you have mild to moderate high blood pressure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
252 people
Ages
19 years to 75 years
Study type
Interventional

Who can take part

  • You are between 19 and 75 years old.
  • You have been diagnosed with high blood pressure (essential hypertension).
  • At the screening visit, your blood pressure is high enough to qualify but not extremely high (under 180/110 mmHg).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05564780Not yet recruiting
Early medicine to prevent heart and stroke in high blood pressure

This trial looks at starting blood-pressure–related medicine early to help prevent heart disease and stroke in people with stage 1 high blood pressure. You may be a candidate if your blood pressure is mildly high and you are not already on blood-pressure medicines.

NCT07064525Enrolling by invitation· Phase 2
Testing a new drug for high blood pressure

This trial tests a new medicine called SPC1001 Low to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure with no known cause). If you are between 19 and 75 years old and have mild to moderate high blood pressure, this study might be an option.

Seoul
NCT07373613Not yet recruiting· Phase 2
Testing new drugs for high blood pressure

This trial tests five new medications to see how well they lower blood pressure in people with essential hypertension (high blood pressure with no known cause). Participants will temporarily stop their current blood pressure medicine during the study.

Soeul
NCT06647745Recruiting· Phase 3
Study for type 2 diabetes and high blood pressure

This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.

Seoul
NCT06790927Not yet recruiting
Standardized blood pressure treatment study

This study tests a standard approach to lowering blood pressure in people whose blood pressure is not well controlled with current treatment. It may help find a more effective way to manage hypertension.

Shanghai, China
NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality

Hear when a new Cardiovascular Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.